http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130064595-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20e5a5907c19bbf92bde146c96a0f10f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d19552134d974272c4f7a77ebc2f1d94 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a7df84eb16b313e361af4f774c31e1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a8165bbde5eb2cc4b35c8c6212f0f48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8839eeec8f5200ae14258853001b9ca3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf84504dd93050985eecf0222b77a970 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd6ab315364195f86cca04bb5c8bdd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f80f7512892d7237fbe6df3ba317a18c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_376936a5d73ed58ce1143ee6248ddeae |
| publicationDate | 2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130064595-A |
| titleOfInvention | Obesity inhibiting composition using grape skin extract as an active ingredient, and a method of manufacturing the same |
| abstract | TLC analysis from grape skin extract lyophilized powder (GSE) to obtain six kinds of purified products with different composition, GSE-F # 1, GSE-F # 3, GSE-F # 4, 3T3-L1 As a result of confirming that the fat accumulation inhibitory activity using the cell was found to be functional in inhibiting obesity, GSE-F # 1 has an antioxidant activity which is an indicator of bioactive substance compared with GSE-F # 3 and GSE-F # 4. Of course, while polyphenol content and flavonoid content were not confirmed, the GSE-F # 4 purified product was found to contain a large amount of bioactive substance by showing an excellent antioxidant capacity as well as polyphenol content and flavonoid content. F # 3 also showed antioxidant activity, polyphenols, and flavonoids, but showed lower results than GSE-F # 4. In terms of function, purified GSE-F # 1 contained insignificant bioactive substances in vitro. Uptake and Cholesterol Influx in Rats and in vivo Test Although the function of inhibiting fat inflow and accumulation was superior to GSE-F # 3 and GSE-F # 4, it did not show excellent fat accumulation inhibitory effect as GSE-F # 1 purified in vitro and in vivo. Since many metabolic syndromes, such as obesity and diabetes, exhibited excellent antioxidant activity against oxidative damage that causes normal cell damage and worsening of symptoms, the purified products of the present invention are not only for inhibiting fat accumulation but also for inhibiting oxidative damage. Has an excellent effect. |
| priorityDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.